Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TetraLogic Pharmaceuticals Corp TLOG

Healthcare Biotechnology
TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two... see more

Recent & Breaking News (GREY:TLOG)

TetraLogic Pharmaceuticals to Present Data From Its Clinical Investigation of SHAPE at the Annual Society of Investigative Dermatology Meeting

GlobeNewswire May 5, 2014

TetraLogic to Present at the Deutsche Bank 39th Annual Healthcare Conference

GlobeNewswire April 30, 2014

TetraLogic Pharmaceuticals Announces Publication of Structural Characterization of Birinapant

GlobeNewswire April 9, 2014

TetraLogic Agrees to Acquire Shape Pharmaceuticals, Inc.

GlobeNewswire April 7, 2014

TetraLogic Pharmaceuticals Announces Publication of Preclinical Characterization of Birinapant

GlobeNewswire April 1, 2014

TetraLogic to Present at the 13th Annual Needham Healthcare Conference

GlobeNewswire March 31, 2014

TetraLogic Pharmaceuticals to Present Data From Its SMAC-Mimetic Program at Upcoming AACR Annual Meeting 2014

GlobeNewswire March 27, 2014

J. Kevin Buchi, President and Chief Executive Officer, Awarded the Pennsylvania Bio's Frank Baldino Bioscience CEO of the Year

GlobeNewswire March 13, 2014

TetraLogic to Present at the Cowen and Company 34th Annual Health Care Conference

GlobeNewswire February 26, 2014

Over 25 Companies to Present at Emerald Groundhog Investment Forum: Thursday, February 6th

Business Wire February 4, 2014

Investment Industry to Gather in Philadelphia at 21st Annual Groundhog Investment Forum

Business Wire January 30, 2014

TetraLogic Announces Licensing and Research Collaboration With Walter and Eliza Hall Institute of Medical Research

Globe Newswire January 21, 2014

RDInvesting Provides Investors with Free In-Depth Equity Reports on MDRX, SNY, SRPT and TLOG

Accesswire January 7, 2014

TetraLogic Announces Exercise of Over-Allotment Option

Globe Newswire December 31, 2013

TetraLogic Pharmaceuticals Corporation [TLOG] to Ring The NASDAQ Stock Market Opening Bell

Globe Newswire December 18, 2013

TetraLogic Announces Closing of Initial Public Offering of Common Stock

Globe Newswire December 17, 2013

TetraLogic Announces Pricing of Initial Public Offering of Common Stock

Globe Newswire December 12, 2013